Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pramipexole for restless legs symptoms in women with X-linked adrenoleukodystrophy
NL-OMON59581Phase 4Completed
- Sponsor
- Amsterdam University Medical Center
- Start
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, double-blind trial of pramipexole in restless legs syndrome (RLS) (3 arms), sponsored by Amsterdam University Medical Center. Primary endpoint: Prevalence of restless legs syndrome in women with ALD. Started Feb 2024; status: completed.
02
Drugs
pramipexole
03
Conditions
restless legs syndrome (RLS)
Beyond the preview
Go deeper on NL-OMON59581.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON59581.